rs61754387
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000372.5(TYR):āc.1112A>Cā(p.Asn371Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,461,438 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N371D) has been classified as Pathogenic.
Frequency
Consequence
NM_000372.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TYR | NM_000372.5 | c.1112A>C | p.Asn371Thr | missense_variant | 3/5 | ENST00000263321.6 | NP_000363.1 | |
TYR | XM_011542970.3 | c.1112A>C | p.Asn371Thr | missense_variant | 3/6 | XP_011541272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TYR | ENST00000263321.6 | c.1112A>C | p.Asn371Thr | missense_variant | 3/5 | 1 | NM_000372.5 | ENSP00000263321 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250990Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135644
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461438Hom.: 0 Cov.: 32 AF XY: 0.00000550 AC XY: 4AN XY: 727028
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Other:1
not provided, no classification provided | literature only | Retina International | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2023 | This sequence change replaces asparagine, which is neutral and polar, with threonine, which is neutral and polar, at codon 371 of the TYR protein (p.Asn371Thr). This variant is present in population databases (rs61754387, gnomAD 0.002%). This missense change has been observed in individual(s) with oculocutaneous albinism (PMID: 29345414). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 3798). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TYR protein function with a positive predictive value of 80%. This variant disrupts the p.Asn371 amino acid residue in TYR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 29345414). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Oculocutaneous albinism Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 22, 2024 | Variant summary: TYR c.1112A>C (p.Asn371Thr) results in a non-conservative amino acid change located in the Tyrosinase copper-binding domain (IPR002227) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 250990 control chromosomes (gnomAD). c.1112A>C has been reported in the literature in individuals affected with Oculocutaneous Albinism (Oetting_1991, King_2003). These data indicate that the variant may be associated with disease. Another missense changer affecting this residue (p.Asn371Tyr) has been determined to be pathogenic, suggesting this is a functionally important residue. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 1642278, 8434585, 13680365, 1676041). ClinVar contains an entry for this variant (Variation ID: 3798). Based on the evidence outlined above, the variant was classified as likely pathogenic. - |
Tyrosinase-negative oculocutaneous albinism Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 15, 1992 | - - |
TYR-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 26, 2024 | The TYR c.1112A>C variant is predicted to result in the amino acid substitution p.Asn371Thr. This variant has been reported in an individual with oculocutaneous albinism (Figure 2, Oetting et al. 1993. PubMed ID: 8434585). An alternate substitution of this amino acid (p.Asn371Tyr) has been reported many times in individuals with oculocutaneous albinism (Table S1, Lasseaux et al. 2018. PubMed ID: 29345414). This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. Given the evidence, we interpret this variant as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at